Back to search
FDAFDA · Food and drugs·Recall number D-0276-2024

Budesonide Extended-Release Tablets, 9 mg, 30-count bottles, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA, UPC 5140782430, NDC 51407-824-30

Published February 7, 2024 · Recall initiated: January 12, 2024

Summary

FDA records drug Class II recall D-0276-2024, published February 7, 2024 and initiated January 12, 2024. Recalling firm: Golden State Medical Supply Inc.; Status: Terminated; Reported quantity: 108 bottles; Lot: Lot #: GS054862, Exp. Date 07/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Golden State Medical Supply Inc.
Distributor
Illinois only
Lot
Lot #: GS054862, Exp. Date 07/31/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Budesonide Extended-Release Tablets, 9 mg, 30-count bottles, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA, UPC 5140782430, NDC 51407-824-30 recalled?

Yes. FDA published recall D-0276-2024 on February 7, 2024. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter